(Bloomberg) -- Blood-testing startup Theranos Inc. said it sent doctors and patients tens of thousands of corrected test results and voided two years of data from its devices, a devastating blow for the company that has come under scrutiny over the accuracy of its technology.
The Silicon Valley startup told federal health regulators at the Centers for Medicare and Medicaid Services that it had voided results from 2014 and 2015 generated by its testing devices, the Wall Street Journal reported. Theranos spokeswoman Brooke Buchanan confirmed the report by e-mail.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
